13 Clinton Dems Say No To Cheaper Drugs


tay
#1
https://t.co/lBmrrBXkuO (external - login to view)


In a statement (external - login to view) to the media after the vote, Booker’s office said he supports the importation of prescription drugs but that “any plan to allow the importation of prescription medications should also include consumer protections that ensure foreign drugs meet American safety standards. I opposed an amendment put forward last night that didn’t meet this test.”

The safety excuse is mostly a chimera, as most of the drugs that would be imported from Canada were originally manufactured in the United States; they’re just cheaper there, because the Canadian government uses a review board and price negotiation to make drugs more affordable.

“My first response to that is show me the dead Canadians. Where are the dead Canadians?” former Minnesota Gov. Tim Pawlenty, a Republican, once asked (external - login to view) during his own push to allow for importation.

“The Democratic Party has got to make it very clear that they are prepared to stand up to powerful special interests like the pharmaceutical industry and like Wall Street, and they’re not going to win elections and they’re not going to be doing the right thing for the American people unless they have the guts to do that,” Sen. Sanders said. “That 13 Democrats did not is disappointing. I absolutely hope that in the coming weeks and months you’re going to see many of them develop the courage to stand up to Pharma.”

Sen. Booker responded to a constituent’s tweet by claiming his “nay” vote was to protect American consumers from potentially harmful ingredients in the drugs, as the amendment didn’t include additional protections for the imported drugs.

Sanders scoffed at the excuse, ...

“If we can import vegetables and fish and poultry and beef from all corners of the Earth, please don’t tell me that we cannot bring in, from Canada and other major countries, name brand prescription drugs of some of the largest corporations in the world,” Sanders said. “That’s a laughable statement.”

Bernie Sanders Shreds Fellow Democrats Who Voted with Big Pharma (external - login to view)


But the Clinton Dems have been there before........


Touting her commitment to lowering healthcare costs, Hillary Clinton this week unveiled a plan (external - login to view) that she says will drive down the skyrocketing price of prescription drugs. The initiative from the Democratic presidential candidate was billed as a challenge to the pharmaceutical industry -- but it is also a rebuke of some of the major pharmaceutical policies of Bill and Hillary Clinton.
During her Iowa campaign event announcing the initiative, Clinton said she wants to allow Americans to purchase medicines from other countries at the lower prices charged there. “If the medicine you need costs less in Canada, you should be able to buy it from Canada, or any country that meets our safety standards,” she said.

As a New York senator, Clinton voted for legislation to allow importation. However, when Congress in 2000 passed such bipartisan legislation, Bill Clinton’s administration used its executive authority (external - login to view) to prevent an importation program from being implemented. At the time, Clinton’s administration said drugs imported from countries like Canada would be unsafe, later prompting bill proponents (external - login to view) to demand to see evidence of mass Canadian casualties from fraudulent drugs. A federal judge recently ruled (external - login to view) that the federal ban on importation invalidates Maine’s first-in-the-nation state statute designed to permit importation.

Candidate Clinton also said that government agencies like Medicare should be able to use their market power to negotiate lower drug prices and that pharmaceutical companies should be able to retain exclusive patent rights to medicines for only a “reasonable period of time.” But as secretary of state, her aides worked on -- and she repeatedly (external - login to view) promoted (external - login to view) -- the Trans-Pacific Partnership, a partnership that critics say includes provisions that could thwart such proposals.

The consumer watchdog group Public Citizen (external - login to view) said a recent leak of the still-secret partnership's text shows it would “reduce the capability of the government to negotiate lower prices” by subjecting them to trade rules.

According to the Center for American Progress (external - login to view) -- which has close ties to the Clintons and is run by Hillary Clinton’s former policy aide (external - login to view) -- the Clinton-backed partnership’s patent provisions “will raise drug prices and hinder access to critical medications.” Economist Dean Baker at the left-leaning Center for Economic and Policy Research has written (external - login to view) that those pact provisions build off World Trade Organization rules backed by President Clinton that toughened international patent protections for drugs.
 
Danbones
Free Thinker
+2
#2  Top Rated Post
guess what stocks they own
 
tay
#3
Deflazacort won a priority review from the agency as a new therapy for Duchenne muscular dystrophy – cutting 4 months off the regulatory process – along with an orphan drug designation and rare pediatric disease status. And today, the FDA handed Marathon Pharmaceuticals a green light (external - login to view) to start marketing the drug to all boys whose lives are being slowly destroyed by the disease.

The corticosteroid will be sold as Emflaza after 1 study involving 196 DMD patients indicated that it could improve the strength of patients with this disease. In another trial with 29 male patients that lasted 104 weeks, the FDA reported, “deflazacort demonstrated a numerical advantage over placebo on an assessment of average muscle strength.”

For that, the company plans to price the drug at $89,000 a year (external - login to view), more than $88,oo0 a year more than what Canadians would pay for the same drug. But like other cases involving price gouging, the company went on to defend the price, saying that insurers will cover most of the price.

In addition to the approval, Marathon wins a rare pediatric disease priority review voucher. These vouchers have fetched hundreds of millions of dollars from drug companies looking for a quick and sure way to slash 4 months off of one of their own drug reviews.
Deflazacort has been available in countries around the world for decades.

Currently, you can buy deflazacort from online pharmacies in Canada for less than a buck a pill.

https://endpts.com/an-old-steroid-br...ed-developers/ (external - login to view)
 
tay
#4
A nonprofit organization that has orchestrated a wide-reaching campaign against foreign drug imports has deep ties to the Pharmaceutical Research and Manufacturers of America, or PhRMA, the powerful lobbying group that includes Eli Lilly, Pfizer and Bayer.

The nonprofit, called the Partnership for Safe Medicines (external - login to view), has recently emerged as a leading voice against Senate bills that would allow drugs to be imported from Canada.

Both the lobbying group and the nonprofit partnership have gone to great lengths to show that drugmakers are not driving what they describe as a grass-roots effort to fight imports, including an expensive advertising blitz and an event last week that featured high-profile former FBI officials and a former Food and Drug Administration commissioner.

However, a Kaiser Health News analysis of groups involved in the partnership shows more than one-third have received PhRMA funding or are local chapters of groups that have received PhRMA funding, according to PhRMA tax disclosures from 2013 to 2015.
Forty-seven of the organizations listed in the ads appear to be advocacy organizations that received no money from PhRMA in those years.

A PhRMA senior vice president, Scott LaGanga, previously led the Partnership for Safe Medicines for 10 years. At PhRMA, LaGanga was responsible for the lobbying group's alliances with patient advocacy groups, and he was simultaneously listed as the executive director of the Partnership for Safe Medicines on each of that group's annual tax filings since 2007, the earliest year for which they are available from ProPublica's Nonprofit Explorer.

A bill cosponsored by Sen. Bernie Sanders (I-Vt.) would provide a mechanism for Canadian drug manufacturers to sell to U.S. consumers and pharmacies. Sanders introduced the bill in February. In January, Sens. John McCain (R-Ariz.) and Amy Klobuchar (D-Minn.) also introduced a bill to allow drug imports from Canada.

In the House, Rep. Elijah Cummings (D-Md.) introduced a similar bill to Sanders', along with 23 other Democrats.

Politico reported in October that PhRMA is bolstering its war chest by another $100 million per year, suggesting to many industry analysts that drugmakers are gearing up for a ferocious fight.

"I think it's safe to say pharmaceutical corporations are prepared to spend some fraction of their multibillion-dollar profits to fight drug importation and any other policy that might end the plague of overpriced medicine," said Rick Claypool, research director for Public Citizen, a watchdog group critical of the drug industry.

Nonprofit Linked To Pharma Lobby Works To Block Drug Imports : Shots - Health News : NPR (external - login to view)
 
Danbones
Free Thinker
#5
...but the Americans want to bomb North Korea because North Korea is competing with the AMERICAN CIA OPIUM IN AFGHANISTANN
and CIA METH with their own Opium and Meth
A Brief History of North Korea (external - login to view)

funny bunch they are

"Two new opioids climbed the ranks, further casting light on the over-prescribing of these pills. A report published by the Centre for Addiction
and Mental Health (CAMH) researchers states while OxyContin prescriptions fell 44 per cent between 2010 to 2013, Hydromorphone increased by 56 per cent and Fentanyl by nearly 16 per cent.

Juurlink says there are millions of people in North America currently on these painkillers, calling it Canada’s biggest drug safety problem."
www.citynews.ca/2016/03/07/op...-of-oxycontin/ (external - login to view)

How Canada got addicted to fentanyl Manufactured in China
http://www.theglobeandmail.com/news/...ticle29570025/

and Perdue in Canada makes the very popular hydromorphs

"Prescriptions of opioid drugs skyrocketing in Canada
A slew of prescription opioids, most notably Purdue Pharma Canada’s Hydromorph Contin, have taken the mantle from oxycodone and are proving as addictive and dangerous"
http://www.theglobeandmail.com/news/...ticle26008639/


its BIG BIG BIG business
Last edited by Danbones; 1 week ago at 03:27 PM..
 
Curious Cdn
Conservative
#6
They're in Pizzerias, too!
 
taxslave
No Party Affiliation
#7
Quote: Originally Posted by tayView Post

Deflazacort won a priority review from the agency as a new therapy for Duchenne muscular dystrophy – cutting 4 months off the regulatory process – along with an orphan drug designation and rare pediatric disease status. And today, the FDA handed Marathon Pharmaceuticals a green light to start marketing the drug to all boys whose lives are being slowly destroyed by the disease.
The corticosteroid will be sold as Emflaza after 1 study involving 196 DMD patients indicated that it could improve the strength of patients with this disease. In another trial with 29 male patients that lasted 104 weeks, the FDA reported, “deflazacort demonstrated a numerical advantage over placebo on an assessment of average muscle strength.”
For that, the company plans to price the drug at $89,000 a year, more than $88,oo0 a year more than what Canadians would pay for the same drug. But like other cases involving price gouging, the company went on to defend the price, saying that insurers will cover most of the price.
In addition to the approval, Marathon wins a rare...

Quote has been trimmed, See full post: View Post
Tere is a good one. "The insurance companies will pay most of it". Upping insurance rates for everyone.
 
no new posts